EAACI Congress 2025
BackOAS05 - Hereditary Angioedema
Friday 13 Jun, 16:45 PM -
18:15 PM Glasgow, United Kingdom
Carron 1
Oral Abstract Sessions
16:45
000481
HAE with normal C1Inh (HAE-n C1INH) and spontaneous mast cell AE (AE-MC): clinical similarities and differences
16:57
000619
Improvements in Quality of Life in Patients With Hereditary Angioedema Receiving Donidalorsen: Post Hoc Analysis From the OASIS-HAE Study and Results From the OASISplus Open-Label Extension
17:09
000394
Bradykinin induces endothelial barrier dysfunction through the modulation of VE-cadherin localization
17:21
001237
The invisible part of Hereditary Angioedema: don’t forget the elderly. An analysis of patients from the ITACA Register
17:33
001607
Real-world evidence study on the effectiveness and safety of lanadelumab in France: the SERENITI study
17:45
001425
Genetic variant spectrum of SERPING1 gene in 46 families residents of Southern Spain with hereditary angioedema with C1-INH deficiency (HAE-C1-INH). Identification of 11 novel variants
